3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Active not recruiting
2
Withdrawn
1
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Lymphoma, Extranodal NK-T-Cell
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia
7
Lymphohistiocytosis, Hemophagocytic
4
Leukemia, T-Cell
2
Epstein-Barr Virus Infections
2
Lymphoma
1
Leukemia, Biphenotypic, Acute
1
Interventions
Cyclophosphamide
4
Vincristine
2
Thioguanine
2
Prednisolone
2
Mitoxantrone
2
Methotrexate
2
Mercaptopurine
2
Melphalan
2
Leucovorin
2
Hydrocortisone
2
Etoposide
2
Daunorubicin
2
Cytarabine
2
Cord Blood Stem Cell Transplantation
2
Asparaginase
2
sargramostim
1
pegaspargase
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Vindesine
1
Therapeutics
1
Tacrolimus
1
Rituximab
1
Psychiatric Rehabilitation
1
Prednisone
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methylprednisolone
1
Levofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia, Biphenotypic, Acute
×
pegaspargase
×
Clear all
NCT00550992
2019-07-30
Interfant06
Dutch Childhood Oncology Group
Phase NA
Unknown
445 enrolled